Abstract
Heparin, which is listed in WHO's Model List of Essential Medicines, 1 WHOWorld Health Organization model list of essential medicines—22nd list, 2021. World Health Organization, Geneva2021 Google Scholar was discovered in 1916 and has been used as an anticoagulant since 1935, possessing potentiating effects on antithrombin. The global demand for heparin is rising, with the global heparin pharmaceutical market projected to grow from US$9·38 billion in 2021 to US$12·06 billion in 2028, and there is a possibility that demand might outstrip supply. 2 Fortune Business InsightsHeparin market: market research report. https://www.fortunebusinessinsights.com/heparin-market-104447Date: 2020 Date accessed: May 8, 2022 Google Scholar In addition to increased usage for treatment of rising cardiovascular disease and thrombosis cases in ageing populations, the demand for heparin has been exacerbated by its use during the COVID-19 pandemic for thromboprophylaxis and treatment of COVID-19-associated thromboembolic disease.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
